https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

CaixaImpulse program

28 de January de 2021

Caixa Impulse program promotes the creation of companies and products in the field of life and health sciences. The program supports innovative projects throughout broad stages of development: from initial validation stages to the point of attraction of private investment or the establishment of agreements with the industry. The program is divided into two different […]

Read more →

Resistance test in the Cantabrian Health Service against COVID-19

14 de December de 2020

The crisis generated by the pandemic derived from COVID-19 in extreme contingency scenarios presents a terrible dilemma: first, it is to protect the health of citizens, although that can hibernate the economy and cause a reduction in income with unequal effects by socioeconomic gradient and by Regional Health Service. In this sense, the Transversal Group […]

Read more →

IDIVAL participates in promoted IMPaCT programs

10 de December de 2020

  On November 20, the provisional resolution for the granting of subsidies for the “Infrastructure of Precision Medicine associated with Science and Technology (IMPaCT)” of the Strategic Action in Health 2017-2020 was published.   IMPaCT is an R + D + i action aimed at the implementation of Precision Medicine in the National Health System […]

Read more →

IDIVAL announces a new internship contract for research support technicians Valdecilla Tec-val

Of the two TEC-VAL contracts called within the Biosanitary Revitalization Plan Aid Program this year, of which only one was covered, IDIVAL once again announces a temporary internship labor contract for the training of support technicians in the Testing Unit Valdecilla clinics (“Tec-Val” Program). The purpose of this program is to promote the professional practice […]

Read more →

SBL Session Vaccines for COVID A new challenge a new development

On December 17, Antonio Fernández, M.D. Director, Business Development & Government Affairs of Johnson & Johnson, gives an online presentation under the title “Vaccines for COVID. A new challenge, a new development ”. Antonio Fernández has a degree in Medicine from the University of Navarra and a graduate of the Executive Development Program of the […]

Read more →

Lung Transplant Patients With COVID-19

Recently, a multicenter retrospective has been published in the American Journal of Transplantation in which six of the seven hospitals that perform lung transplantation in Spain have participated and which are the following: Vall d'Hebron (Barcelona), La Fe (Valencia) , Marqués de Valdecilla (Santander), Reina Sofía (Córdoba), Puerta de Hierro (Madrid), October 12 (Madrid), and […]

Read more →

First results of immunological inflammatory diseases and SARS-CoV-2

8 de September de 2020

The Marqués de Valdecilla University Hospital Rheumatology Unit, in collaboration with the Valdecilla Health Research Institute (IDIVAL), has launched a study to determine the relationship between immunological inflammatory diseases and SARS-CoV-2. Developed by doctors Ricardo Blanco, Miguel Ángel González-Gay and David Martínez-López, the objectives of this research in patients with rheumatological diseases with an immune […]

Read more →

EuroBioHighTech European Event on Innovation and Smart Health

1 de September de 2020

On 3rd and 4th September we invite you to Trieste at EuroBioHighTech 2020, the satellite event of the European Science Open Forum, the main European research event. EBHT is a unique event dedicated to Smart Health and Innovation for Businesses. The main players are: universities, investors, innovative companies and public institutions operating in the field […]

Read more →

IDIVAL rewards Dr Luis Rojas Marcos for his research career

28 de August de 2020

IDIVAL presents the award for his research career to Dr. Luis Rojas Marcos and the award for health cooperation for development to Dr. Pedro Cavadas. The award ceremony will take place during the XIII Inter-regional Meeting on Legal Protection of the Patient organized by the University Menéndez Pelayo International and directed by Jorge Tomillo, Professor […]

Read more →

Valdecilla participates in an international study investigating a vaccine against Coronavirus

The Marqués de Valdecilla University Hospital has been one of the 3 Spanish hospitals selected to participate in an international study investigating a vaccine, Ad26COVS, against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 disease. Thanks to the collaboration of healthy volunteers, the aim is to evaluate the immune response to different doses of […]

Read more →